Attempting to set a discriminating adiponectin level, they found that 77% of patients with NASH had adiponectin <10 μg/mL and HOMA-IR >3, compared to 33% of patients with simple steatosis. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.